{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:41:04Z","timestamp":1782362464237,"version":"3.54.5"},"update-to":[{"DOI":"10.12688\/f1000research.24094.1","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000}},{"DOI":"10.12688\/f1000research.24094.2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000}}],"reference-count":33,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009530","name":"Jawaharlal Institute Of Postgraduate Medical Education and Research","doi-asserted-by":"publisher","award":["JIP\/Res\/Intra-MD\/phs2\/2016-17"],"award-info":[{"award-number":["JIP\/Res\/Intra-MD\/phs2\/2016-17"]}],"id":[{"id":"10.13039\/501100009530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>\n                    <ns4:bold>Background<\/ns4:bold>\n                    : Frequent asymptomatic involvement of the prostate has been demonstrated in men with febrile urinary tract infection (fUTI). In view of this, men with fUTI are often given a longer duration of antibiotic treatment; however, evidence to support this is limited.\n                  <\/ns4:p>\n                  <ns4:p>\n                    <ns4:bold>Methods<\/ns4:bold>\n                    : We prospectively studied adult men with fUTI admitted under the Department of Medicine in a tertiary care hospital in southern India. \u00a0fUTI was defined as fever of \u226538\u00b0C with at least one symptom\/sign of UTI and pyuria, requiring hospitalization. We estimated serum total prostate-specific antigen (PSA) levels at enrollment, one month and three months after treatment completion. We assessed prostatic volume by transrectal ultrasonography (TRUS) and estimated the serum high sensitivity C-reactive protein (hs-CRP) levels at baseline and after three months.\n                  <\/ns4:p>\n                  <ns4:p>\n                    <ns4:bold>Results<\/ns4:bold>\n                    : We enrolled 64 men (median [IQR] age 53 [45-60] years); 50 patients completed follow-up. At baseline, 24 (38%) of 64 patients had elevated serum PSA values compared to age-specific upper limit. The median (IQR) serum PSA level was 2.15 (1.18-3.02) ng\/mL and median (IQR) serum hs-CRP level was 2.23 (1.85-2.74) mg\/dL (N=64). At three months, serum PSA levels decreased by \u226525% in 47 (94%) of 50 patients. The median (IQR) of prostatic volume was 25.4 (18.9-34) mL at baseline (N=64), and \u226510% decrease in prostatic volume was observed in 24 (48%) of 50 patients at three months. The change in the serum PSA levels did not correlate with clinical findings like prostatic tenderness or with prostatic volume changes. Further, serum PSA levels did not correlate with hs-CRP levels. On follow-up, seven patients had lower urinary tract symptoms; only one of them had recurrent fUTI. \u00a0\n                  <\/ns4:p>\n                  <ns4:p>\n                    <ns4:bold>Conclusions<\/ns4:bold>\n                    : Asymptomatic prostatic involvement, although common in men with fUTI, does not seem to influence the treatment outcomes.\n                  <\/ns4:p>","DOI":"10.12688\/f1000research.24094.3","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T07:40:12Z","timestamp":1604994012000},"page":"617","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Frequency and clinical significance of prostatic involvement in men with febrile urinary tract infection: a prospective observational study"],"prefix":"10.12688","volume":"9","author":[{"given":"Thayyil Shahilal","family":"Arjunlal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2151-4273","authenticated-orcid":false,"given":"Surendran","family":"Deepanjali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramanitharan","family":"Manikandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajappa","family":"Medha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2020,11,10]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"S216-227","DOI":"10.1093\/clind\/15.supplement_1.s216","article-title":"Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration.","volume":"15 Suppl 1","author":"R Rubin","year":"1992","journal-title":"Clin Infect Dis."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"97-101","DOI":"10.1097\/QCO.0000000000000024","article-title":"Urinary tract infections and bacterial prostatitis in men.","volume":"27","author":"F Wagenlehner","year":"2014","journal-title":"Curr Opin Infect Dis."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"470-474","DOI":"10.1046\/j.1464-410x.1999.00164.x","article-title":"Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography.","volume":"84","author":"P Ulleryd","year":"1999","journal-title":"BJU Int."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"157-161","DOI":"10.1016\/j.ejim.2004.01.020","article-title":"Accurate topographical diagnosis of urinary tract infection in male patients with (111)indium-labelled leukocyte scintigraphy.","volume":"15","author":"M Velasco","year":"2004","journal-title":"Eur J Intern Med."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"571-578","DOI":"10.1007\/s11908-011-0211-y","article-title":"Treatment duration of febrile urinary tract infections.","volume":"13","author":"W van der Starre","year":"2011","journal-title":"Curr Infect Dis Rep."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"89-93","DOI":"10.1016\/s0924-8579(03)00228-0","article-title":"Febrile urinary tract infection in men.","volume":"22 Suppl 2","author":"P Ulleryd","year":"2003","journal-title":"Int J Antimicrob Agents."},{"key":"ref-7","article-title":"Antibiotic resistance","year":"2018"},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"86-91","DOI":"10.1097\/QCO.0000000000000222","article-title":"Bacterial prostatitis.","volume":"29","author":"B Gill","year":"2016","journal-title":"Curr Opin Infect Dis."},{"key":"ref-9","article-title":"National Health and Nutrition Laboratory Protocol","year":"2002"},{"key":"ref-10","first-page":"507-512","article-title":"A hospital based study on reference range of serum prostate specific antigen levels.","volume":"140","author":"A Gupta","year":"2014","journal-title":"Indian J Med Res."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"24-27","DOI":"10.1159\/000474140","article-title":"Prostate-specific antigen and prostatitis in men under fifty.","volume":"30","author":"V Pansadoro","year":"1996","journal-title":"Eur Urol."},{"key":"ref-12","first-page":"445-449","article-title":"Prostate-specific antigen levels in acute and chronic bacterial prostatitis.","volume":"39","author":"M Yamamoto","year":"1993","journal-title":"Hinyokika Kiyo."},{"key":"ref-13","doi-asserted-by":"crossref","first-page":"138-143","DOI":"10.4103\/0970-1591.21530","article-title":"Measurement of serum PSA in benign and malignant enlargements of prostate in Indian population: relevance of PSAD in intermediate range PSA.","volume":"20","author":"M Agarwal","year":"2004","journal-title":"Indian J Urol."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"122-125","DOI":"10.4103\/0970-1591.32060","article-title":"Age-specific prostate specific antigen and prostate specific antigen density values in a community-based Indian population.","volume":"23","author":"A Ganpule","year":"2007","journal-title":"Indian J Urol."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"132-137","DOI":"10.1007\/BF02872408","article-title":"Racial and ethnic variation of PSA in global population: Age specific reference intervals for serum prostate specific antigen in healthy South Indian males.","volume":"19","author":"T Malati","year":"2004","journal-title":"Indian J Clin Biochem."},{"key":"ref-16","first-page":"114-120","article-title":"Acute Bacterial Prostatitis: Diagnosis and Management.","volume":"93","author":"T Coker","year":"2016","journal-title":"Am Fam Physician."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"1529-1537","DOI":"10.1002\/pros.22700","article-title":"Prostate specific antigen enhances the innate defence of prostatic epithelium against Escherichia coli infection.","volume":"73","author":"C Townes","year":"2013","journal-title":"Prostate."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"1592-1599","DOI":"10.1002\/pros.20414","article-title":"Activation of innate immunity by prostate specific antigen (PSA).","volume":"66","author":"J Kodak","year":"2006","journal-title":"Prostate."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"113-116","DOI":"10.1002\/pros.2990200206","article-title":"Prostate specific antigen and prostatitis. II. PSA production and release kinetics in vitro.","volume":"20","author":"T Moon","year":"1992","journal-title":"Prostate."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"1937-1942","DOI":"10.1016\/S0022-5347(05)00892-X","article-title":"Sexually transmitted infections and prostatic inflammation\/cell damage as measured by serum prostate specific antigen concentration.","volume":"175","author":"S Sutcliffe","year":"2006","journal-title":"J Urol."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"2221-30","DOI":"10.1002\/ijc.29966","article-title":"Infectious mononucleosis, other infections and prostate-specific antigen concentration as a marker of prostate involvement during infection.","volume":"138","author":"S Sutcliffe","year":"2016","journal-title":"Int J Cancer."},{"key":"ref-22","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/120535","article-title":"Chikungunya Virus Infection and Acute Elevation of Serum Prostate-Specific Antigen.","volume":"2015","author":"W Aiken","year":"2015","journal-title":"Case Rep Urol."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"114-120","DOI":"10.1080\/0036554021000027018","article-title":"Transrectal prostatic ultrasonography in acute bacterial prostatitis: findings and clinical implications.","volume":"35","author":"J Horcajada","year":"2003","journal-title":"Scand J Infect Dis."},{"key":"ref-24","article-title":"Urological infections"},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2334-8-12","article-title":"Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis.","volume":"8","author":"M Etienne","year":"2008","journal-title":"BMC Infect Dis."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"89-93","DOI":"10.12954\/PI.12013","article-title":"Clinical courses following acute bacterial prostatitis.","volume":"1","author":"B Yoon","year":"2013","journal-title":"Prostate Int."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"7-10","DOI":"10.1111\/j.1464-410X.2008.07495.x","article-title":"Management of bacterial prostatitis: what's new?","volume":"101","author":"K Naber","year":"2008","journal-title":"BJU Int."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"62-68","DOI":"10.1001\/2013.jamainternmed.829","article-title":"Urinary tract infection in male veterans: treatment patterns and outcomes.","volume":"173","author":"D Drekonja","year":"2013","journal-title":"JAMA Intern Med."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"1254-1255","DOI":"10.1001\/jamainternmed.2016.3646","article-title":"The New Antibiotic Mantra -\u201cShorter Is Better\u201d.","volume":"176","author":"B Spellberg","year":"2016","journal-title":"JAMA Intern Med."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12916-017-0835-3","article-title":"Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women.","volume":"15","author":"C van Nieuwkoop","year":"2017","journal-title":"BMC Med."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"e0197302","DOI":"10.1371\/journal.pone.0197302","article-title":"Stopping the effective non-fluoroquinolone antibiotics at day 7 vs continuing until day 14 in adults with acute pyelonephritis requiring hospitalization: A randomized non-inferiority trial.","volume":"13","author":"P Rudrabhatla","year":"2018","journal-title":"PLoS One."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"93-96","DOI":"10.1111\/j.1464-410x.2004.04642.x","article-title":"Acute prostatitis in middle-aged men: a prospective study.","volume":"93","author":"S Kravchick","year":"2004","journal-title":"BJU Int."},{"key":"ref-33","article-title":"Prostatic involvement in male UTI.","author":"S Deepanjali","year":"2020","journal-title":"figshare."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/9-617\/v3\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/9-617\/v3\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/9-617\/v3\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T19:26:46Z","timestamp":1697052406000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/9-617\/v3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,10]]},"references-count":33,"URL":"https:\/\/doi.org\/10.12688\/f1000research.24094.3","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.30628.r74492","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.30628.r74492","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,10]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/9-617\/v3#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.30053.r73746, Veeravan Lekskulchai, Department of Pathology, Faculty of Medicine, Srinakharinwirot University, Bangkok, Thailand, 28 Oct 2020, version 2, 1 approved, 1 approved with reservations","URL":"https:\/\/f1000research.com\/articles\/9-617\/v2#referee-response-73746","order":0,"name":"referee-response-73746","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.30628.r74492, Aneesh Basheer, Departments of General Medicine and Medical Education, Pondicherry Institute of Medical Sciences, Pondicherry, Pondicherry, India, 23 Nov 2020, version 3, indexed","URL":"https:\/\/f1000research.com\/articles\/9-617\/v3#referee-response-74492","order":1,"name":"referee-response-74492","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"This work was supported by an intramural research grant by the Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry [JIP\/Res\/Intra-MD\/phs2\/2016-17]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}